SUMMARY
The Fund rose 9.7% in December.
- Significant investment in Brazilian Rare Earths with IPO return of 32%, exploring high-grade sources.
- Market updates include Clarity Pharmaceutical’s 33% rise, Immutep’s 17% increase, and Major Drilling’s strong results.
- Opthea rises 8% after securing funding, with further funding expected; major Phase 3 studies to begin.